Tenet Healthcare (NYSE:THC) Updates FY 2025 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 11.740-12.840 for the period, compared to the consensus estimate of 11.080. The company issued revenue guidance of $20.6 billion-$21.0 billion, compared to the consensus revenue estimate of $21.3 billion.

Tenet Healthcare Trading Down 0.7 %

Shares of NYSE THC opened at $138.52 on Wednesday. Tenet Healthcare has a 1-year low of $86.90 and a 1-year high of $171.20. The company has a market cap of $13.17 billion, a PE ratio of 4.44, a P/E/G ratio of 0.63 and a beta of 2.05. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. The company has a 50-day moving average of $133.85 and a two-hundred day moving average of $148.52.

Wall Street Analysts Forecast Growth

THC has been the subject of a number of research analyst reports. UBS Group boosted their target price on shares of Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 target price for the company. in a research note on Friday, November 22nd. Barclays boosted their price target on shares of Tenet Healthcare from $171.00 to $190.00 and gave the stock an “overweight” rating in a research note on Friday, November 8th. Cantor Fitzgerald boosted their price target on shares of Tenet Healthcare from $168.00 to $177.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 30th. Finally, KeyCorp dropped their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $165.00.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.